GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cdkn1b | increases expression | ISO | CDKN1B (Homo sapiens) | 6480464 | CTD | Mifepristone results in increased expression of CDKN1B mRNA; Mifepristone results in increased expression of CDKN1B protein | PMID:34537908 | Cdkn1b | multiple interactions | ISO | CDKN1B (Homo sapiens) | 6480464 | CTD | Mifepristone inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CDKN1B protein]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of CDKN1B mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of CDKN1B protein]; Mifepristone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein]; Mifepristone promotes the reaction [CDK2 protein binds to CDKN1B protein]; Mifepristone promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein]; Mifepristone results in increased expression of and results in increased localization of CDKN1B protein | PMID:17283133 PMID:17545545 PMID:22266097 PMID:34537908 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |